Ideaya Biosciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $207,834 | $0 | $0 | $7,000 |
Gross Profit | 206,804 | -1,233 | -1,133 | 6,357 |
EBITDA | 120,274 | -76,258 | -71,045 | -129,669 |
EBIT | 119,244 | -77,491 | -72,178 | -130,312 |
Net Income | 119,244 | -77,491 | -72,178 | -130,312 |
Net Change In Cash | 207,834 | 0 | 0 | 7,000 |
Free Cash Flow | 142,172 | -63,137 | -61,672 | -122,757 |
Cash | 298,927 | 114,645 | 129,996 | 84,378 |
Basic Shares | 89,690 | 88,472 | 88,356 | 87,340 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $7,000 | $23,385 | $50,931 | $27,941 |
Gross Profit | 3,166 | 19,377 | 50,931 | 27,941 |
EBITDA | -270,643 | -108,953 | -60,401 | -48,543 |
EBIT | -274,477 | -112,961 | -62,502 | -50,268 |
Net Income | -274,477 | -112,961 | -54,808 | -47,531 |
Net Change In Cash | 7,000 | 23,385 | 50,931 | 27,941 |
Cost of Revenue | -23,414 | 20,009 | ||
Free Cash Flow | -251,441 | -117,592 | -90,618 | -58,423 |
Cash | 84,378 | 157,018 | 68,632 | 92,046 |
Basic Shares | 81,678 | 57,519 | 41,444 | 35,252 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | $1.33 |
2025-06-30 | -$0.88 |
2025-03-31 | -$0.82 |
